Development of computerized alerts with management strategies for 25 serious drug-drug interactions

被引:10
|
作者
Murphy, John E. [1 ]
Malone, Daniel G. [1 ]
Olson, Bridget M. [2 ]
Grizzle, Amy J.
Armstrong, Edward P. [1 ]
Skrepnek, Grant I. [1 ]
机构
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[2] Dymaxium Inc, San Diego, CA USA
关键词
Ambulatory care; Computers; Drug interactions; Quality assurance; QUESTIONNAIRE SURVEY; GENERAL-PRACTICE; PRIMARY-CARE; COMMUNITY;
D O I
10.2146/ajhp070046
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The development of computerized alerts with management strategies for 25 drug-drug interactions (DDIs) is described. Summary. To ensure that clinicians, when confronted with any of 25 serious DDIs in the ambulatory care setting, can avoid these DDIs while treating patients with appropriate medications, management strategies were developed using a consensus approach. Several methods were used to ensure that the recommended alternatives were truly safe. Four well-stablished drug-interaction compendia were screened, and any potential alternative agent that was listed as having an interaction (moderate or serious in nature) was excluded from the list of alternative agents. Case reports, case series, and clinical studies that focused on the alternative combinations were reviewed to determine if the alternative posed interaction risks. If an interaction for the alternative combination had not been identified in the compendia or in the literature search, other potential mechanisms for drug interactions were explored such as alterations in absorption, distribution, metabolism, or excretion. Pharmacology and therapeutics textbooks and other drug information sources also served as resources. In general, the strategies included alternatives to both medications, changing dosage or increasing monitoring of one of the agents, situations where one of the medications had no alternative but alternatives were available for the other medication, and alternative methods of birth control. In some situations the two drugs were contraindicated, while in others the two drugs should be avoided if at all possible and alternatives used. Conclusion. Consensus-based management strategies for 25 serious DDIs were developed for inclusion in computerized alert messages.
引用
收藏
页码:38 / 44
页数:7
相关论文
共 50 条
  • [31] NOACs: drug-drug interactions
    Hudzik, Bartosz
    Lekston, Andrzej
    Gasior, Mariusz
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2016, 188 (05) : 369 - 369
  • [32] DRUG-DRUG INTERACTIONS IN PERSPECTIVE
    HANSTEN, PD
    NORTHWEST MEDICAL JOURNAL, 1974, 1 (03): : 43 - 45
  • [33] DRUG-DRUG INTERACTIONS WITH FLUOROQUINOLONES
    MARCHBANKS, CR
    PHARMACOTHERAPY, 1993, 13 (02): : S23 - S28
  • [34] COMPUTERIZED DRUG-DRUG INTERACTION SCREENING SYSTEM
    GREENLAW, CW
    ZELLERS, DD
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (05): : 567 - 570
  • [35] Drug-drug interactions in the elderly
    Björkman, IK
    Fastbom, J
    Schmidt, IK
    Bernsten, CB
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (11) : 1675 - 1681
  • [36] KINETICS OF DRUG-DRUG INTERACTIONS
    AARONS, L
    PHARMACOLOGY & THERAPEUTICS, 1981, 14 (03) : 321 - 344
  • [37] KINETICS OF DRUG-DRUG INTERACTIONS
    ROWLAND, M
    MATIN, SB
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (06): : 553 - 567
  • [38] Avoiding Drug-Drug Interactions
    Astrand, Bengt
    CHEMOTHERAPY, 2009, 55 (04) : 215 - 220
  • [39] DRUG-DRUG INTERACTIONS IN THE NEWBORN
    CONTERAS, EA
    SUTTER, TK
    LOHLA, ER
    PHAN, DK
    NEUROBEHAVIORAL TOXICOLOGY AND TERATOLOGY, 1985, 7 (02): : 204 - 204
  • [40] Drug-drug interactions in urology
    Michel, M. C.
    Schaefers, R. F.
    de la Rosette, J. J. M. C. H.
    UROLOGE, 2009, 48 (03): : 264 - +